Terveystalo Oy
Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral heal… Read more
Terveystalo Oy (TTALO) - Net Assets
Latest net assets as of June 2025: €544.80 Million EUR
Based on the latest financial reports, Terveystalo Oy (TTALO) has net assets worth €544.80 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.40 Billion) and total liabilities (€854.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €544.80 Million |
| % of Total Assets | 38.93% |
| Annual Growth Rate | 9.63% |
| 5-Year Change | -4.08% |
| 10-Year Change | 148.75% |
| Growth Volatility | 28.9 |
Terveystalo Oy - Net Assets Trend (2014–2024)
This chart illustrates how Terveystalo Oy's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Terveystalo Oy (2014–2024)
The table below shows the annual net assets of Terveystalo Oy from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €548.20 Million | +6.36% |
| 2023-12-31 | €515.40 Million | -12.94% |
| 2022-12-31 | €592.00 Million | -2.78% |
| 2021-12-31 | €608.90 Million | +6.54% |
| 2020-12-31 | €571.50 Million | +5.60% |
| 2019-12-31 | €541.20 Million | +5.74% |
| 2018-12-31 | €511.80 Million | +11.92% |
| 2017-12-31 | €457.30 Million | +96.89% |
| 2016-12-31 | €232.27 Million | +5.39% |
| 2015-12-31 | €220.38 Million | +0.87% |
| 2014-12-31 | €218.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Terveystalo Oy's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16781100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €77.90 Million | 14.21% |
| Common Stock | €100.00K | 0.02% |
| Other Comprehensive Income | €485.40 Million | 88.54% |
| Total Equity | €548.20 Million | 100.00% |
Terveystalo Oy Competitors by Market Cap
The table below lists competitors of Terveystalo Oy ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Caida Securities Co Ltd
SHG:600906
|
$1.02 Billion |
|
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
|
$1.02 Billion |
|
Galapagos NV
PINK:GLPGF
|
$1.02 Billion |
|
China Sports Industry Group Co Ltd
SHG:600158
|
$1.02 Billion |
|
InventisBio Co. Ltd. A
SHG:688382
|
$1.02 Billion |
|
Bell Food Group AG
LSE:0RFX
|
$1.02 Billion |
|
Bitdeer Technologies Group Class A Ordinary Shares
NASDAQ:BTDR
|
$1.02 Billion |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
$1.02 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Terveystalo Oy's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 515,400,000 to 548,200,000, a change of 32,800,000 (6.4%).
- Net income of 71,700,000 contributed positively to equity growth.
- Dividend payments of 38,000,000 reduced retained earnings.
- Other comprehensive income decreased equity by 2,200,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €71.70 Million | +13.08% |
| Dividends Paid | €38.00 Million | -6.93% |
| Other Comprehensive Income | €-2.20 Million | -0.4% |
| Other Changes | €1.30 Million | +0.24% |
| Total Change | €- | 6.36% |
Book Value vs Market Value Analysis
This analysis compares Terveystalo Oy's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.82x to 2.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | €1.98 | €9.56 | x |
| 2015-12-31 | €1.99 | €9.56 | x |
| 2016-12-31 | €1.99 | €9.56 | x |
| 2017-12-31 | €3.92 | €9.56 | x |
| 2018-12-31 | €4.00 | €9.56 | x |
| 2019-12-31 | €4.25 | €9.56 | x |
| 2020-12-31 | €4.47 | €9.56 | x |
| 2021-12-31 | €4.77 | €9.56 | x |
| 2022-12-31 | €4.66 | €9.56 | x |
| 2023-12-31 | €4.06 | €9.56 | x |
| 2024-12-31 | €4.33 | €9.56 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Terveystalo Oy utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.08%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.35%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 2.55x
- Recent ROE (13.08%) is above the historical average (2.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -38.01% | -17.48% | 0.68x | 3.17x | €-104.71 Million |
| 2015 | 0.50% | 0.22% | 0.70x | 3.30x | €-20.82 Million |
| 2016 | 5.44% | 2.30% | 0.75x | 3.17x | €-10.58 Million |
| 2017 | 1.57% | 1.04% | 0.76x | 1.97x | €-38.52 Million |
| 2018 | 13.43% | 9.23% | 0.64x | 2.27x | €17.53 Million |
| 2019 | 10.00% | 5.25% | 0.76x | 2.51x | €-20.00K |
| 2020 | 8.01% | 4.64% | 0.72x | 2.38x | €-11.35 Million |
| 2021 | 13.22% | 6.97% | 0.80x | 2.38x | €19.61 Million |
| 2022 | 4.12% | 1.94% | 0.85x | 2.50x | €-34.80 Million |
| 2023 | -8.19% | -3.28% | 0.91x | 2.75x | €-93.74 Million |
| 2024 | 13.08% | 5.35% | 0.96x | 2.55x | €16.88 Million |
Industry Comparison
This section compares Terveystalo Oy's net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.